Chris Freitag
Vice President
hematology/oncology
Debiopharm
Switzerland
Biography
Dr Freitag obtained his Medical Degree from Kiel University, Germany in 1994. Following several posts in hematology/oncology, internal and respiratory medicine in the UK, Dr Freitag moved to Australia to work in emergency medicine and rural/remote practice for almost 4 years. In 2001, Dr Freitag moved to the pharmaceutical industry in Pharmacovigilance/drug Safety with Roche. After 6 years in PV and Medical Affairs, he joined Shire in the UK as Director of Clinical Medicine. At Shire, he held several positions in clinical development and medical affairs, covering the internal medicine portfolio, finally as VP, Global Clinical development and Innovation. In 2014 he joined BTG plc in the UK as SVP to Head up Vascular Medicine and went on to lead global clinical development across the portfolio in oncology, respiratory medicine, interventional vascular medicine and specialty pharmaceuticals/antidote products. He joined Debiopharm International SA in 2016.
Research Interest
Pharmacovigilance/drug Safety
